Product
DHAX
1 clinical trial
4 indications
Indication
Diffuse Large B-Cell LymphomaIndication
High-grade B-cell lymphomaIndication
B-Cell LymphomaIndication
Follicular Lymphoma Grade 3BClinical trial
A Phase Ib Study With Expansion Cohorts Evaluating the Safety and Efficacy of Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Autologous Stem Cell Transplant-Eligible Patients With Relapsed/Refractory Aggressive B Cell LymphomaStatus: Recruiting, Estimated PCD: 2026-04-30